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The New Zealand government (through its agency the Ministry of Agriculture and 
Forestry, MAF) seeks to mitigate the potential negative impacts of importation through 
requiring commodities that may pose a risk to New Zealand’s primary production 
systems, human health, indigenous flora, fauna or biodiversity to have an import health 
standard. Given, potential import opportunities exist in a wide variety of commodities 
from many different countries, the demand for import health standards far outweighs 
MAF’s available resources to develop them. Therefore MAF must have a framework 
that prioritises which import health standards will be developed. This paper briefly 
presents the framework MAF is currently using to undertake the prioritisation of import 
health standards and then discusses how the current framework could evolve to become 
more ‘economics-based’.  
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Introduction 
 
The concept of ‘gains from trade’ has a long history in economics, indeed the 
profession’s founding father, Adam Smith, propounded the notion in his seminal work, 
“An Inquiry into the Nature and Causes of the Wealth of Nations” in 1776.  
 
“Whether the advantages which one country has over another be natural or acquired is in this respect of no 
consequence. As long as the one country has those advantages, and the other wants them, it will always be 
more advantageous for the latter rather to buy of the former than to make”.  
(The Wealth of Nations, Book IV, Chapter II). 
 
If a foreign country can supply us with a commodity cheaper than we ourselves can make it, better buy it 
of them with some part of the produce of our own industry employed in a way in which we have some 
advantage....It is certainly not employed to the greatest advantage when it is thus directed towards an 
object which it can buy cheaper than it can make.
(The Wealth of Nations, Book IV, Chapter II). 
                                                           
1 The views expressed are the authors and do not necessarily reflect the views of Biosecurity New Zealand 
or the Ministry of Agriculture and Forestry.  
The growth in both the volume and participation in global trade over time indicates that 
countries too recognise these gains and are actively seeking to capture them.  However, 
whilst trade can be immensely beneficial to countries who engage in it, the actual 
commodities traded can also have severe negative impacts on the societies that receive 
them, particularly if the importation of these commodities is allowed unchecked. 
 
The New Zealand government seeks to mitigate the negative impacts of importation on 
New Zealand by requiring imported commodities to comply with the following Acts or 
conventions: 
•  Customs and Excise Act 1996; 
•  Hazardous Substances and New Organisms Act 1996; 
•  Convention on Trade in Endangered Species of wild fauna and flora; and 
•  Biosecurity Act 1993.  
This paper focuses on the last of these Acts: the Biosecurity Act. Section 22 of the 
Biosecurity Act allows the Director-General of the Ministry of Agriculture and Forestry 
(MAF) to issue an import health standard specifying the requirements to be met for the 
effective management of risks associated with the importation of risk goods. In practice, 
biosecurity risk goods cannot be imported without an import health standard.
2 Risk 
goods, in the biosecurity sense, can be thought of as any commodity that may harbour 
organisms that are a risk to New Zealand’s primary production systems, human health, 
indigenous flora, fauna or biodiversity. The rationale behind import health standards is 
that because the control or eradication of invasive species is often technically difficult 
and therefore costly, reducing the risk pre-border through the requirement of risk goods 
to have an import health standard is a cost effective biosecurity risk management 
strategy. 
  
Given potential import opportunities exist in a wide variety of commodities from many 
different countries, the demand for import health standards far outweighs Biosecurity 
New Zealand’s available resources to develop them. The absence of a price for import 
health standards means that the rationing problem must be solved in other ways.
3 
Therefore Biosecurity New Zealand needs a framework that selects which import health 
standards will be developed. The large number of applications received (over 300 in the 
application round for the 2006/07) means the selection framework needs to be simple 
and quick to use (ruling out a detailed cost benefit analysis of each application), whilst 
                                                           
2 We cannot however refuse a request for import health standards only prioritise them lower. 
3 The traditional impediments to charging for import health standards are (from Sinner and Gibbs, 1998):
 (a) the “free rider” problem (the first applicant pays for the import health standard to be developed, but all 
subsequent importers  get the benefit of being able to import under it); and 
(b) charging for “generic” import health standards that cover all country sources for a specific commodity 
or pathway (such as sea containers), rather than a specific country/commodity combination. 
However, both MAF (2004b) and Denyer et al. (2003) feel there is a strong economic case for charging 
for import health standards. MAF is currently in the process of designing a system that will allow this to 
happen. There is currently an option for importers to voluntary self fund applications.    
  
 
 ensuring that that the applications selected to be progressed are the ones that have the 
largest net benefit to New Zealand.  
 
This paper is set out as follows. Section 2 outlines the ideal framework at a conceptual 
level. Section 3, gives a brief overview of the past and present systems for prioritising 
import health standards. Section 4 outlines how we believe the framework for 
prioritising import health standards could evolve. Section 5 concludes.   
The framework at a conceptual level 
 
A simple characterisation of the government’s objective functions when prioritising 
import health standards is given in equation (1): 
 
Max U(x)                                                                                               (1) 
  x 
 
subject to p.x=y 
 
Where x is the vector of import health standard applications chosen to be developed, p is 
the vector of cost to the government of developing the import health standards chosen 
and y is the portion of Vote: Biosecurity allocated toward developing import health 
standards.  
 
We are seeking to extract a preference order on the set of import health standard 
applications such that x= x*, where x* is the set of import health standard applications 
that will maximize the government’s objective function specified in (1). 
 
In an ideal world we would be searching for a social welfare function or a social choice 
rule, which transforms the set of individual preferences from each member of the public 
into a single global societal preference order. Arrow’s (1950) well known result 
(Arrow’s impossibility theorem) shows that under a set of reasonable requirements and 
if there are more than two individuals and three options to decide between then it is 
impossible to design a social welfare function that satisfies these reasonable 
requirements.
4 We follow Brown and Jackson (1986) in regarding Arrow’s result not as 
a stumbling block, but as benchmark against which social choice rules can be compared 
(in the same way perfectly competitive markets are used to make welfare judgements 
about alternative market structures). Brown and Jackson (1986) offer the solution that a 
social welfare function that is related to the intensity of individual preferences will allow 
a societal preference order to be reached.
5
 
                                                           
4 These reasonable requirements are: unrestricted domain, the Pareto principle, the independence of 
irrelevant alternatives, and individual utilities that are ordinally measurable and interpersonally 
noncomparable. 
5 This type of system fails to conform to Arrow’s requirements since preferences are regarded as being 
cardinal rather than ordinal. We assume that the intensity of preferences is a positive linear function of the positive 
attributes of the commodity’s importation and a negative linear function its negative 
attributes (however these are measured). That is: 
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Where vi(xi) is the value of import i to New Zealand. Equation (3) states the value of 
import i to New Zealand is a positive function of the value placed on each of the positive 
attributes of an import, where a is an attribute from the full set of attributes A desirable 
in any import and l(a) is the value placed on attribute a. vi(xi) is also a positive function 
of the relative importance of the attribute a for commodity i, wi, where ∑ .   
∈ =
A a ai w 1
 
Equation (3) also states the value of an import to New Zealand is negative function of 
the disutility associated with the negative attributes of an import, where z is an attribute 
from the full set of attributes Z undesirable in any import, vi(xi) is also a negative 
function of the relative significance of that attribute for commodity i, yi, where 
.    ∑ ∈ =
Z z ai y 1
 
As stated above we are seeking to find the subset of applications {1…n}, from the full 
set of applications {1…m} that maximizes (2a) subject to our budget constraint as stated 
in equation (2b); pi represents the cost of doing application i and y again is the portion of 
Vote: Biosecurity allocated toward developing import health standards.  
 
 
In order for the set of applications that maximises (2a) to be selected (‘prioritised’) we 
need a transparent scoring system which allows a structured approach for the positive 
and negative attributes to be assessed. Dooley et al. (2006) note that the features of 
multiple criteria decision making include: 
•  making the decision transparent;  
•  providing a means of problem structure; and  
•  providing a quantitative means to assist with decision making when there are 
multiple and conflicting goals measured in different units (the most obvious 
example in this context is an import that is economically beneficial but harmful 
to the environment). 
Multiple criteria analysis therefore appears to be the most logical framework under 
which to conduct import health standard prioritisation. There have been various attempts 
to develop a multiple criteria import health standard prioritisation system; in the next 
section we outline these attempts.  
Past and present systems  
 
Prior to 2005 (when an informal version of the current system was used) each of the 
sector groups (plant, forestry and animal) ran a separate system to prioritise import 
health standards. The three systems are outlined below. 
 
Denyer et al. (2003) state there was some broad criteria and guidelines for how import 
health standards in the animal sector should be prioritised. First priority was “current 
biosecurity concerns” (for example, disease outbreaks in other countries, changes in 
current knowledge, and changes in exporting country disease status). Second priority 
was work already under way. Other areas listed in the import health standard procedures 
to consider when determining priorities include:  
•  response to trade issues;  
•  environmental impact; 
•  economic impact; volume of trade; 
•  likelihood of illegal importation; and 
•  the number of people requesting a particular risk analysis or import health 
standard.  
Otherwise, the order of priority is “first in, first served”. Denyer et al. (2003) note this 
process appears to lead to two possible outcomes: 
(a) the request be given high priority ranking, in which case it is entered into the work 
programme; or 
(b) the request is not considered a high priority, in which case it remains on the “waiting 
list”. 
 
The plant sector (excluding forestry) prioritised applications based on:
 6   
•  Overseas exporter priority for the application (for example, it is a specifically 
requested import health standard from an overseas government);  
•  value of the crop if grown in New Zealand and consequences if a pest incursion;  
•  ability to treat potential high impact pests off-shore;  
•  New Zealand importer interest and potential market; 
•   technical (i.e. how hard will it be to get the required information); and  
•  political requirements. 
 
Dooley et al. (2003) report the system for prioritising import health standards in the 
forestry sector involved assessing application against the following criteria:  
•  potential economic risk; 
•  potential environmental risk; 
•  potential societal risk (human health); 
•  potential economic benefit; 
•  potential societal benefit; and 
                                                           
6 Veronica Herrera, per. com.  •  level of trade collaboration (this category had double the weighting of any other). 
 
For the sake of brevity we refrain from providing detailed comment of these past 
systems. However we offer that the forestry system seems most aligned to a system that 
focused on the positive and negative attributes of importing the commodity, with the 
plant system also appearing to be reasonably consistent with this paradigm (although it 
is also based on importer and exporter interest); however the positive and negative 
attributes of the commodities importation appear to be secondary consideration in the 
animal system.  
 
It was recognised that an allocation system where prioritisation occurred separately in 
individual sector groups failed to make best use of limited resources to maximise the 
(net) benefits of trade. The original argument for treating the prioritisation processes as 
separate was that the resource required to develop import health standards is specialized 
to the sector group and therefore cannot be substituted into the other process (you can 
not change plant scientists into animal scientists over night). While this is true, the 
funding used to pay that resource is directly substitutable (i.e. there is an opportunity 
cost in funding an import health standard in one sector group as it could be used to fund 
an import health standard in sector group). By indicating the sector group(s) in which the 
more (net) beneficial import health standards could be developed, prioritising all 
applications in a single process will give direction to how the resource should be split 
between each sector group. If the current resource split differs from the optimal resource 
split, resource reallocation should occur. There will be a degree of inertia in this 
resource reallocation due to the costs associated with hiring and firing workers (and 
therefore even if animal applications are ranked consistently above plant applications, 
some plant applications may still be developed in the short run because the resource is 
available and leaving it idle would be even more inefficient). However, in the long run 
the resource mix should change to ensure an optimal split. 
 
The above thinking was the basis for formally prioritising all applications together using 
a process based on the biosecurity Integrated Risk Management Framework (hereafter 
the IRMF) in 2006.
7 The IRMF is Biosecurity New Zealand’s current prioritisation 
framework (although it is currently under review) which aims to guide the allocation of 
resources for the management of risks across the biosecurity system.  
 
The IRMF identifies five criteria on which grounds to prioritise the use of biosecurity 
resources to manage risk; these are technical feasibility, practical feasibility, benefit-
cost, strategic considerations, and acceptability. Options for risk management are scored 
against the criteria outlined above.  
 
Given the criteria in the IRMF are meant to apply to across the biosecurity system they 
are necessarily general in nature. Below, we describe how the general criteria from the 
IRMF were applied in the specific context of the prioritisation of import health standard 
applications.  
 
                                                           
7 MAF (2004a). The first criterion relates to the technical feasibility of the application; that is, the 
complexity of the task. When assessing an application against this criterion, the 
assessors were asked to consider: 
•  What information is needed to develop the import health standard? 
•  What technical information is currently available? (For example, published risk 
assessments, international codes or standard, peer refereed articles, or findings of 
research projects). 
•  How easily will it be to generate the information that is not currently available? 
An application scored lowly on the technical criterion if information was not easily 
available or easily sourced, the import health standard would be complex to carry out 
and/or there is a high risk that the import health standard development would be held up 
due to non co-operation from the exporting country. 
 
The second criterion relates to the net benefit (benefit minus cost) to New Zealand of 
carrying out the import health standard. Assessment of benefits and costs was carried out 
against the following values: 
•  Economic; 
•  Health; 
•  Environment; and 
•  Social  
In order to define the scope of benefits and costs considered we needed to define a 
baseline scenario relative to which to assess them against. In the case of an import health 
standard application for a commodity that is not currently traded or if the commodity is 
being sourced from a new country, we consider no trade (with that country) as the 
baseline. The reason this is selected as the baseline is simply a reflection of the current 
practice that trade cannot commence for a commodity considered to be a biosecurity risk 
until an import health standard for its importation has been approved. Table 1 reports 
some of the specific guidance given assessors on what to consider when doing this 
assessment.  
 
By contrast, when scoring the benefit-cost criterion for the review of an existing import 
health standard, the baseline scenario is trade. If the commodity’s biosecurity risk status 
has increased since its import health standard was last reviewed, the benefits of the 
review is the lower biosecurity risk which will result if more stringent risk management 
procedures are placed on its importation. If the commodity’s biosecurity risk status has 
decreased since its import health standard was last reviewed, the benefits of the review 
are lower compliance costs and the (probable) increase in the volume trade that will 
probably result from less stringent risk management procedures being put in place. 
Additionally there maybe benefits if undertaking the import health standard will result in 
more efficient import health standard conformance. Efficiency could result from 
updating risk mitigation measures meaning compliance with the import health standard 
is cheaper for the importer or decreasing inspection time resulting in lower MAF 
Quarantine Service costs.  
 Table 1: Benefits and costs associated with the importation of a previously untraded 




•  Consumers get access to cheaper product and/or more variety 
•  Potential economic benefits to other industries. For example, import is used as an input in another 
production process, meaning that industry now has access to cheaper or better inputs.  
 
Environmental 
•  Possible environmental benefits may relate to anything that assists with species survive or the 
enhancement of natural features.  
 
Cultural/Spiritual 
•  Special significance the imported commodity may have certain cultures or religions. 
 
Health 
•  Possible benefits include nutritional value, reduced mortality, improvement of general health or use for 
medical purposes. 
 
Costs include … 
Economic 
•  Cost of MAF of doing the IHS.  
•  Costs to the importer of complying with requirements of the IHS. The costs of compliance with the import 
health standard which are borne by MAF, the importer and the general public are unlikely to be known for 
a specific commodity until the import health standard is completed, however an assessment can be made 
based on previous experience with similar commodities. The argument for including the costs of 
compliance is as follows: 
-  even though the importer usually bears most of the cost of complying with the import health standard, it 
is still a cost to them and therefore needs to be considered if we are considering the costs and benefits 
from a national point of view of undertaking this import health standard (although in national terms the 
cost is unlikely to be significant). 
-  the use of MAF or public resources to enforce the risk management procedures outlined in an import 
health standard has an opportunity cost associated with it. The use of resource to provide quarantine 
facilities, for example has an opportunity cost has those resources could be used else in the system to 
manage biosecurity risk.  
 
•  Any potential costs associated with increased biosecurity risk due to the importation of the commodity is 
not considered; as the risk management measures outlined in the import health standard are assumed to 
decrease this risk to a negligible level. If this were not the case, then any additional biosecurity risk would 
need to be considered under this criterion. 
 
•  The IRMF states “excluded from consideration as relevant economic factors [in cost-benefit analysis] are 
any benefits in protecting domestic producers from competition from imported risk goods, and, it is 
argued costs to consumers who benefit from the importation of risk goods,” (p. 17). The reason for this is 
that denying market access on grounds other than those identified in the Agreement on the Application of 
Sanitary and Photosanitary Measures could expose New Zealand to international legal challenge or afford 
other countries the opportunity to restrict the importation of our exports on non-technical considerations. 
 
Environmental 




•  Will its importation offend certain cultures or religions? 
 
Health 
•  Will this have a negative New Zealander’s nutrition, mortality or general health? The resource used to fund new import health standards or reviews of existing import 
health standards is the same and therefore despite the distinctions made above with 
regard to the baseline scenario, applications for new applications and reviews are 
assessed on the same scale.  
 
The strategic criterion relates to how the importation of the commodity would contribute 
or align with the goals and key priorities of Biosecurity New Zealand and the New 
Zealand government. When assessing an application against this criterion, the panel 
members considered if is was a priority for: 
•  the Minister of Biosecurity? 
•  in terms of wider government policy? 
•  in terms of MAF’s statement of intent? 
•  in terms of the Biosecurity framework? or 
•  as part of the regulatory process? 
 
Assessment guidelines state applications will score highly on this criterion if it is a very 
high priority for MAF or the government (to the extend it is almost mandatory). For 
example if the guarantee of a certain import health standard was a requirement for 
securing a Free Trade Agreement, or part of a government to government request. 
 
The final criterion, practicality, relates to the MAF’s ability to undertake the import 
health standard.
 8 If used as a prioritisation criterion, an application would score highly 
on this criterion if MAF can easily undertake the import health standard with the 
resources available to it. These resources may be either ‘in house’ or easily contractible. 
However given the way we have defined the practicality criterion as relating to MAF’s 
ability to undertake the import health standard. We felt it was more appropriate for an 
application to be checked against the ‘practicality’ criterion after the application had 
been against prioritised against the other criteria. That is, the ‘practicality’ criterion does 
not contribute to determining priority rather it is a check against whether the application 
should proceed or not. The reason we are advocating this approach is that the goal of this 
prioritising system is to ensure that resources are allocated in such a way that is best for 
New Zealand, not what is best for MAF. Prioritising something higher because MAF can 
do it is contrary to this goal. Indeed the long term goal of this system is to ensure MAF’s 
resource mix changes so we can do the import health standards that are best for New 
Zealand. However, as discussed above, there will be a degree of inertia in changing this 
resource mix in the short run therefore the practicality criterion was used as a check to 
ensure we presently have the resources to do it. It is important if a priority application 
cannot be done due to lack of specialised resource to record this and feed it back into 
business planning to ensure the adjustment of resource mix occurs to allow optimal 
resource allocation in the long run.  
                                                           
8 In the IRMF there is also a fifth criterion, ‘acceptability’. We did not score applications against this 
criterion because it was feared having a criterion that reflected public support for an application may mean 
domestic producers (i.e. potential competitors with the import) may have an incentive to undertake 
behaviours that will see an application score low on the acceptability criterion just so they avoid the threat 
of competition.  
  
Applications were scored against the strategic, technical and net benefit criteria on a 0-6 
scale to generate an initial ranking;
 9 panel members were then asked if they agreed with 
the ranking. The reason we asked panel members to check if they agreed with the 
ranking is because under the scoring system a score of ‘2’ is superior to ‘4’ for a 
category, however it is not necessarily twice as superior than ‘4’ and therefore straight 
aggregation of the scores is not appropriate. For straight aggregation to be appropriate 
going from 1 to 2 needs to have the same impact on utility as going from 4 to 5; that is 
the utility associated with an application and the criterion score must be a linear function 
of each other.
 10 For utility to be a linear function of a criterion’s score some form of 
calibrating (through a revealed preference survey, for example) would need to happen to 




The evolution of the system 
 
Criticisms of the present process 
 
At the conclusion of the prioritisation process, panel members were asked to express 
their feelings on the prioritisation process. One point raised was: “[t]o improve the 
defendability of the process, MAF should continue to clarify the criteria descriptors.  
The clearer the descriptors are, the more accurate the result is likely to be”. (Import 
health standard prioritisation panel meeting minutes, 22 March 2006).  
 
We feel the lack of clarity actually stems from the fact that the criteria are overlapping.
11 
The strategic criterion is really a subset of the benefit criteria, whilst the technical 
criterion is an indication of how difficult the import health standard will be to undertake 
and therefore an indicator of cost.  
 
Our proposed system 
 
The system we are proposing is based on the concept that importation of the commodity 
will both positively and negatively impact on New Zealander’s economic, natural 
environment, human health and social/ cultural well-beings (‘the four outcomes’) plus 
government.
12 We believe this is a superior to the current approach as it does not matter 
where the source of the benefit or cost comes from, their influence will be captured by 
                                                           
9 For brevity we have omitted the descriptors for each score for each category. 
10 Additionally for aggregation to be possible, an increase of 1 point in each category would have to result 
in the same increase in utility no matter what category the increase occurred in.  
11 For the sake of clarity ‘we’ from now on especially refers to the author’s views and not the views of 
MAF or Biosecurity New Zealand. 
12 There will therefore ten criteria consisting of the positive and negative impacts of each of the four 
outcomes plus government. how they impact on the outcomes.
13  Figure 1 shows the source of the benefit could be 
strategic (as defined under the current system) or a benefit of the commodity itself. 
Similarly the negative impacts on our outcomes could result from such sources as:  
•  residual risk that treatment measures in the risk mitigation procedures (in the 
import health standard) are unable to treat; 
•   the impacts of the risk mitigation procedures themselves (if they affect New 
Zealanders; for example, the impacts on the environment of any fumigation 
carried out in New Zealand); and  
•  compliance costs incurred by New Zealand importers and the Ministry of 
Agriculture and Forestry staff (either head office or Quarantine service) in 
ensuring compliance with the import health standard.
14  
The net impacts of doing a review are essentially the same as discussed in the section on 






                                                           
13 It also links with the shifting paradigm in the public service of managing for outcomes.   
14 In line with the SPS agreement (WTO, 1994) we do not include the impacts on domestic producer as a 
cost.   
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When trying to estimate the positive and negative impacts of a new import or a review 
on our outcomes there will be considerable uncertainty.  Uncertainty will arise for a 
number of reasons:   
•  uncertainty inherent in what the positive and negative impacts of the import will 
be;  
•  uncertainty as to the accuracy and actual availability of knowledge; and  
•  uncertainty from assessors themselves concerning their own knowledge. 
One way to manage this uncertainty is through belief nets (also known as Bayesian 
Networks, probability nets, causal nets). Belief nets manage uncertainty by explicitly 
representing the dependencies between the different components of the impact. This 
provides an intuitive graphical visualization of the impact including the interactions 
among the various sources of the impact.  
 
In our application, the nets represent, and give structure to, a ‘top down’ thought process 
where we progress down the diagram to the point where we know enough about the 
subcomponent to ‘score it’ accurately. We then use this information to help us assign a 
score to the broad outcomes (economic, social, health, environment and government) by 
combining the impacts on each subcomponent to formulate an overall score for the 
outcome.  A subcomponent is any of the boxes in the nets that is not the broad outcome; for example in figure A1 (in Appendix 1), health is the broad outcome and mental health 
and anxiety are examples of subcomponents. 
 
Figures A1-A5 (in Appendix 1) outline our initial thinking on what the nets could look 
like for each of the four outcomes plus government. These nets can then be used to 




To clarify consider the following example. Say we are seeking to score the positive 
impacts of the importation of Mangos on the health outcome. The information we have 
about Mangos is that it reduces the risk of colon cancer, is a rich source of beta carotene 
(which the body converts to Vitamin A) and is also a source of fibre and Vitamin C.
16 If 
we are unsure how to ‘score’ these positive health benefits we could use figure A1 as 
outlined in table 2. 
 
Table 2: Mango Importation Example 
Level one questions  Level two questions 
How will the outcome ‘physical health’ 
be affected? 
Can not say with certainty- so go to the 
next level 
How will the outcome ‘energy and 
nutrition’ be affected? 
Given there is currently little or no 
domestic supply and importation is 
limited, this importation will increase the 
supply of nutritional benefits associated 
with Mangoes but there is little marginal 
benefit as Vitamins A, C and fibre are 
available cheaply from other sources.  
  How will ‘degree of mobility’ be 
affected? 
Say with sufficient certainty that its 
unlikely to be affected materially 
  How will ‘ability to undertake self care’ 
be affected? 
Say with sufficient certainty that its 
unlikely to be affected materially 
  How will ‘degree of pain or discomfort’ 
be affected? 
The consumption of mango is unlikely to 
reduce your degree of pain or discomfort. 
  How will the outcome ‘mortality’ be 
affected? 
Moderately if reduces the risk of colon 
cancer. 
How will ‘mental health be affected? 
Say with sufficient certainty that its 
unlikely to be affected materially- 





The first step is to see if we can answer the ‘Level 1’ questions with certainty: Does the 
consumption of mangoes affect mental health? We can say with acceptable certainty that 
                                                           
15 For brevity we have not given an explanation of each of these diagrams and the interconnections. It is 
probable this will form the basis for a separate paper once these nets for each of the outcomes have been 
finalised. We stress these nets are very much in draft form, we present them to illustrate the concept rather 
than the detail that goes into each net. 
16 Source of this information and information in table 2 is www.health24.com and 
www.freshmangoes.com.   it does not and therefore we do not have drop down to the next level. Does consumption 
of mangoes affect physical health? We are unsure the extent to the importation of 
Mangoes will have positive impacts of physical health (we know it will have some as it 
a source of vitamin A, C and fibre). So therefore we drop down to level 2 to help us 
reduce the uncertainty around this answer. We do know that it will increase the supply 
of vitamins A,C and fibre so therefore the ‘energy and nutrition’ outcome will be 
improved; although the marginal increase is unlikely to be that large as there are other 
cheap, readily available sources of vitamins A and C and fibre. It is clear that through 
reducing the risk of colon cancer, the importation of Mangoes will impact positively on 
the mortality subcomponent. While we can confidently say the consumption of Mangoes 
is unlikely to materially affect positively the ‘degree of mobility’, ‘ability to under take 
self care’ and ‘degree of pain or discomfort’ outcomes. There maybe secondary impacts 
from reducing the risk of colon cancer but we feel to make the assessment tool more 
manageable, it is better to focus on primary effects and therefore the reduction in the risk 
of colon cancer is picked up through the mortality. We then use the information we have 
from level 2 to make an assessment about the positive impact of the importation of the 
physical health outcome (how we could do this will be discussed below). 
 
The ‘nets’ could either be semi-qualitative or quantitative tool to help assess the impacts 
of an import health standard.  If this tool was used as a semi-qualitative tool, figures A1-
A5 could be used to provide structure on what is considered under each of our five 
outcomes; for example, if deciding what the positive impacts of Mango importation will 
be on the health outcome, panelists know that they must consider the impact on physical 
and mental health (and the outcomes under these headings) in the structured way 
outlined above. Panelists could then come up with a qualitative description for that 
impact on this outcome based on the information. However, given the large number of 
application there need to be a numerical value placed on both the positive and negative 
impacts for each of the outcomes to allow applications to be ranked.  If, for example, a 
panelist feels there are ‘significant’ positive impacts on the health outcomes from the 
importation of Mangos after working through figure A1 then on that basis they may 
chose to assign a score of ‘8’ for the ‘positive impacts on the health outcome’ criterion. 
 
 The use of this tool as a quantitative assessment tool would require the scoring of each 
of the subcomponents (at the level where you have sufficient certainty) with these 
subcomponents having a relationship/weight to the subcomponent above (with weights 
needing to be agreed upon). Using the same example of the positive impact on the health 
outcome of Mango importation, say panelists agree of scoring and weightings as 
outlined below in table 3. Table 3: Example of a Quantitative Use of the Proposed New System  
Outcome ‘Level  1’ 
Input  
‘Level 2’ Input  Score  Weight 
Health (positive 
impacts) 
    1.05  1 
Mental health    0  0.5   
Physical health     2.1  0.5 
Mobility  0 0.15 
Discomfort  0 0.15 
Self care   0 0.15 
Mortality  4 0.4 
 
Energy and nutrition  3 0.15 
note: The bold scores  in this table have been calculated using scores from  level below .For 
example,  the score for mental health  is calculated by multiplying the scores for by their weights.  
 
The score for the positive impacts on the health outcome criterion would therefore be 
1.05. This is the sum of the weighted average for the score for physical and mental 
health; with the score for physical health being a weighted average of the scores 
assigned to its subcomponents (mobility etc)  
 
On balance, we believe the qualitative use of this tool is the more appropriate in this 
context. We base this conclusion on two factors, firstly the quantitative process 
described above is very time consuming, which is concerning given the large numbers of 
applications received. Secondly while the quantitative approach does give explicit values 
to wi, we believe being too prescriptive about the weights and scores gives the process a 
spurious accuracy. Because our net approach is not, and does not pretend to be, a 
comprehensive list of what could be impacted we believe it is dangerous to lose the 
ability to exercise judgement by imposing such a rigorous framework. It needs to be 
noted that with this scoring system (whether qualitative or quantitative) allowing 
aggregation of the categories without panel moderation is still not possible because we 
have yet to address the problem of ensuring a one point increase in each category is an 
equivalent to an equal increase (decrease) in utility for positive (negative) impacts 
(similarly increasing the score by 1 within a category should result in an identical 




We do not pretend that any of the frameworks discussed above are anything but crude 
measures of the net welfare an import will bring to New Zealand. However by adopting 
the structured approach of multi criteria analysis the choices between applications for 
import health standard development are made explicit and transparent. As Dooley et al. 
(2005) note this allows people to identify the key drivers of decisions as well as 
providing a structured process to help people think through and understand the decision. 
After all no framework can make decisions for you rather it can only be used as a guide 
for decision making- the decision making is up to panelists.   
We believe the proposed evolution of the prioritisation system from what were initially 
three separate processes with different criteria to an integrated system assessing priority 
based on impacts on outcomes (rather than the source of the impact as is currently the 
case) will result in the selection of applications that will go some way to maximizing the 
social welfare function stated in (1).    
 
 
However in saying this, the new system proposed by the author still needs some work. 
Specifically key priorities include developing a scoring system that reflects both the 
significance of the group/ sector being impacted on as well as the marginal impact on 
our outcomes of the commodity’s importation (i.e. how much is the import adding to the 
outcome compared to the status quo).  
 References 
 
Arrow, K. (1950), A Difficulty in the Concept of Social Welfare, The Journal of 
Political Economy, 58 (4), pp. 328-346. 
 
Brown, C.V. and Jackson, P.M. (1986), Public Sector Economics, Third Edition, Basil 
Blackwell, Oxford.  
 
Denyer, M., Gallacher, S., Johnson, N., Ogden, S. and White, A. (2003), Keeping Pace 
with Change”- An Independent Review of Biosecurity IHS Development, 
MinterEllisonRuddWatts and Market Access Solution NZ, 7 August 2003. 
 
Dooley, A.E., Sheath, G.W. and Smeaton, D. (2005), Multiple Criteria Decision 
Making: Method Selection and Application to Three Contrasting Agricultural Case 
Studies, Paper presented to the 2005 New Zealand Agricultural and Resource Economics 
Society’s Annual Conference, Nelson 2005.  
 
MAF (2004a), Biosecurity Integrated Risk Management Framework, Biosecurity 
Strategy Implementation Team, 30 June 2004.  
 
MAF (2004b), Future Funding of Biosecurity Services, Biosecurity New Zealand 
Discussion Paper 04/01, December 2004. 
 
MAF (2006), Import Health Standard Prioritisation Panel Meeting Minutes, 22 March 
2006.  
 
Sinner, J; Gibbs, N. (1998), Development of a Decision-Making Framework for the 
Analysis and Management of Biosecurity Risks – Stage 2 Report: Current Practice in 
Managing Biosecurity Risks, April 1998. 
 
Smith, A. (1776), An Inquiry into the Nature and Causes of the Wealth of Nations, W. 
Strahan & T. Cadell, London.  
 
WTO (1994), The WTO Agreement on the Application of Sanitary and Photosanitary 





                                                              Appendix 1: Well being nets 
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